Steffen Ventz

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, Shah PD, Ballinger TJ, Yang ES, Vinayak S, Melisko M, Brufsky A, DeMeo M, Jenkins C, Domchek S, D'Andrea A, Lin NU, Hughes ME, Carey LA, Wagle N, Wulf GM, Krop IE, Wolff AC, Winer EP, Garber JE.

J Clin Oncol. 2020 Dec 20. 38(36):4274-4282. PMID: 33119476

Shared and Usable Data From Phase 1 Oncology Trials-An Unmet Need.

Arfè A, Ventz S, Trippa L.

JAMA Oncol. 2020 Jul 01. 6(7):980-981. PMID: 32496530

A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly.

Tabrizi S, Trippa L, Cagney D, Tanguturi S, Ventz S, Fell G, Wen PY, Alexander BM, Rahman R.

Neuro Oncol. 2020 Apr 27. PMID: 32339235

To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.

Vanderbeek AM, Ventz S, Rahman R, Fell G, Cloughesy TF, Wen PY, Trippa L, Alexander BM.

Neuro Oncol. 2019 10 09. 21(10):1239-1249. PMID: 31155679

Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial Designs.

Ventz S, Trippa L, Schoenfeld JD.

Clin Cancer Res. 2019 12 15. 25(24):7281-7286. PMID: 31527164

Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications.

Rahman R, Fell G, Ventz S, Arfé A, Vanderbeek AM, Trippa L, Alexander BM.

Clin Cancer Res. 2019 11 01. 25(21):6339-6345. PMID: 31345838

Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

Ventz S, Lai A, Cloughesy TF, Wen PY, Trippa L, Alexander BM.

Clin Cancer Res. 2019 08 15. 25(16):4993-5001. PMID: 31175098

Divining responder populations from survival data.

Rahman R, Ventz S, Fell G, Vanderbeek AM, Trippa L, Alexander BM.

Ann Oncol. 2019 06 01. 30(6):1005-1013. PMID: 30860592

Bayesian Adaptive Randomization in Dose-Finding Trials.

Ventz S, Alexander BM, Trippa L.

JAMA Netw Open. 2018 12 07. 1(8):e186075. PMID: 30646308

The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

Vanderbeek AM, Rahman R, Fell G, Ventz S, Chen T, Redd R, Parmigiani G, Cloughesy TF, Wen PY, Trippa L, Alexander BM.

Neuro Oncol. 2018 07 05. 20(8):1034-1043. PMID: 29518210